---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-092999"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2026-08-10T10:50:13+00:00"
generated_at: "2026-08-10T10:55:21.892637+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Accendra Health Q2 revenue down 10%, adjusted loss; CEO Pesicka to retire by end of 2026

## Summary
- Q2 net revenue $613.2M, down 10% YoY from $681.9M; GAAP EPS -$1.16 vs -$1.09.
- Adjusted EBITDA $60.1M vs $96.6M; adjusted EPS -$0.19 vs +$0.26; free cash flow -$25.1M.
- Reduced total debt by $385M in Q2 via balance sheet optimization closed in June.
- CEO Ed Pesicka to retire by end of 2026; will step down from Board; succession process underway.
- Eliminated over $125M annualized operating expense from large commercial payor exit.

## SEC filing metadata
- accession: 0001104659-26-092999
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2026-08-10T10:50:13+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000110465926092999/0001104659-26-092999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000110465926092999/tm2622667d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-092999
- JSON: https://secwatch.observer/filing/0001104659-26-092999.json
- Plain text: https://secwatch.observer/filing/0001104659-26-092999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.